TIRmed Pharma raises 5.4 MSEK in equity to continue pursuing preclinical development of new antiviral treatment and a topical treatment for atopic eczema.

Eczema is a common disease affecting up to 20% of children and approximately 3% of adults, with a drugs market estimated up to 75 BSEK worldwide. The intense itch associated with the condition can lead to sleeping disorders, anxiety and depression. There is no cure as of today. The current treatments can ameliorate the symptoms…. Read more »

New publication

Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide Authors: Aleksandra Dondalska, Elin Rönnberg, Haisha Ma, Sandra Axberg Pålsson, Elin Magnusdottir, Tianle Gao, Lucille Adam, Ethan A. Lerner , Gunnar Nilsson, Malin Lagerström and Anna-Lena Spetz Front. Immunol., 30 September 2020  https://doi.org/10.3389/fimmu.2020.559589